PleuraSeal Post Market Study (Europe)

Completed · Phase 4

Conditions studied: Lung Disease, Pulmonary Lobectomy

In brief

To further characterize the PleuraSeal Sealant System as compared to standard of care (sutures and staples only) in subjects undergoing an elective pulmonary lobectomy and segmentectomy via open thoractomy.

Key facts

Study ID

NCT00704171

Run by

Integra LifeSciences Corporation

People needed

121

Starts

2008-01-01

Expected to finish

2008-12-01

Last updated by the study team

2016-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Covidien — Bedford, Massachusetts, United States
• Universitaetsklinik - Landeskrankenhaus Innsbruck — Innsbruck, Austria
• Otto Wagner Spital — Vienna, Austria
• Hopital Erasme — Brussels, Belgium
• University Hospitals Leuven — Leuven, Belgium
• VU-Medisch Centrum — Amsterdam, Netherlands
• Medical Centre Rotterdam Zuid — Rotterdam, Netherlands
• University Hospital - Zurich — Zurich, Switzerland
• Papworth Hospital — Cambridge, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.